- Home
- Applications
- lung cancer foundation and the joan gaeta lung cancer
Lung Cancer Foundation And The Joan Gaeta Lung Cancer Product Applications For The Served Medical Health Care Industry
9 applications found
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed. ...
ByTC BioPharm based in Holytown, UNITED KINGDOM
Like other nanocarriers, synthetic exosomes can be used to treat different types of cancer successfully, by encapsulating the desired anti-tumoral drug or RNA and enzymes. Several studies have used engineered exosomes from dendritic or macrophage cells to release chemotherapeutic compounds as doxorubicin, paclitaxel miRNA or siRNA to induce antitumoral activity. Rodent mammary carcinoma, mice lung cancer, glioma and pancreatic cancer are just some targeted diseases in preclinical testing using exosome delivery ...
ByNanovex Biotechnologies based in Llanera, SPAIN
The presence of a nodule in your lung, more commonly known as a mass or “spot” on your lungs, can be quite scary. However, a lung nodule or mass is a lot more common than you might think. Many nodules are benign, meaning that they are not cancer. It is important to know what type of lung nodule you have. ...
ByAuris Health, Inc. based in Redwood City, CALIFORNIA (USA)
Lung cancer is the leading cause of cancer deaths worldwide. More Americans die each year from lung cancer than from prostate, breast and colon cancers ...
ByAuris Health, Inc. based in Redwood City, CALIFORNIA (USA)
Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively. Early diagnosis is important for preserving lung function. Once a diagnosis of any type of rare lung disease is confirmed, patients will be closely monitored for the development of complications, including lung infection, pneumothorax (collapsed lung), or end-stage lung disease. Earlier diagnosis, leading to earlier initiation of preventative therapies, can improve long-term lung ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
ByBiocept based in San Diego, CALIFORNIA (USA)
Simply script for a “multi-function ventilator.” Patients must meet the medical necessity for ventilation and only one additional therapy (oxygen, cough, suction, or ...
ByVentec Life Systems based in Bothell, WASHINGTON (USA)
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)